The Gut-Brain Axis: Dietary, Probiotic, and Prebiotic Interventions on the Microbiota examines the potential for microbial manipulation as a therapeutic avenue in central nervous system disorders in which an altered microbiota has been implicated, and explores the mechanisms, sometimes common, by which the microbiota may contribute to such disorders.
- Focuses on specific areas in which the microbiota has been implicated in gut-brain communication
- Examines common mechanisms and pathways by which the microbiota may influence brain and behavior
- Identifies novel therapeutic strategies targeted toward the microbiota in the management of brain activity and behavior
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
ISBN-13
978-0-12-802544-4 (9780128025444)
Schweitzer Klassifikation
1. Global and Epidemiological Perspectives on Diet and Mood2. Targeting the microbiota: Considerations for developing probiotics as functional foods3. Food- and non-food based strategies for effective delivery of probiotics4. Bioactive- and non-bioactive food constituents and their influence on the microbiome5. Correlating the gut microbiome to health and disease6. The microbiome and aging: Impact on health and wellbeing7. Importance of the microbiota in early life and influence on future health8. Utility of microbial genome sequencing in probiotic strain identification: Promises and pitfalls9. Germ-Free Animals: A Key Tool in Unravelling How the Microbiota Affects Brain and Behavior10. Sensitivity of the hypothalamic-pituitary-adrenal axis to the gut microbiota: Opportunities for dietary intervention11. A neuroactive microbiome12. The influence of diet and the gut microbiota in schizophrenia13. Influence of the microbiota on the development and function of "the second brain" - the enteric nervous system 14. Dietary inventions and brain-gut disorders15. Altering the gut microbiome for cognitive benefit?16. The role of the microbiota in neurodevelopmental disorders17. The role of the microbiota and potential for dietary intervention in chronic fatigue syndrome18. Potential for pre - and probiotics in managing psychological symptoms associated with alcohol-dependence19. Where next for dietary intetventions and the brain-gut axis?20. Perspectives on targeting the microbiome in developing global populations21. Regulatory considerations for the use and marketing of probiotics and functional foods22. Microbiota and Metabolism
